A Window-of-opportunity Study of Pelareorep in Early Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Pelareorep|DRUG: Letrozole|DRUG: Atezolizumab|DRUG: Trastuzumab
Sponsor: Oncolytics Biotech
Collaborators: SOLTI Breast Cancer Research Group